Encouraged by this study, we postulated a hypothesis that pro-inflammatory and pro-apoptotic immune mechanisms in subjects with low AAT level could protect against HCC in liver cirrhosis and assessed the risk of HCC in MZ and MS genotype carriers in a large group of patients with advanced liver cirrhosis of various aetiologies. This evidence concerns the gene SERPINA1 and hepatocellular carcinoma.